Differential influences of gold sodium thiomalate and bucillamine on the generation of CD14+ monocyte-lineage cells from bone marrow of rheumatoid arthritis patients

Clinical Immunology and Immunopathology

Volumn 84, Issue 3, 1997, Pages 290-295

  Hirohata, Shunsei ^a   Yanagida, Tamiko ^a   Hashimoto, Hideo ^b   Tomita, Tetsuya ^b   Ochi, Takahiro ^b   Nakamura, Hiroshi ^c   Yoshino, Shin'ichi ^c  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; BUCILLAMINE; CD14 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0031239874     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4375     Document Type: Article

References (16)

1. Firestein G. S., Zvaifler N. J. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 33:1990;768-773.
2. Hamilton J. A. Rheumatoid arthritis: Opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet. 342:1990;536-539.
3. +. Arthritis Rheum. 39:1996;836-843.
4. Conaghan P. G., Brooks P. Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, andD. Curr. Opinion Rheumatol. 7:1995;167-173.
5. Harth M. Mechanisms of action of disease modifying antirheumatic drugs. J. Rheumatol. 19:1992;100-113.
6. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S., Medsger T. A. Jr., Mitchell D. M., Neustadt D. H., Pinals R. S., Schaller J. G., Sharp J. T., Wilder R. L., Hunder G. G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
7. +. Arthritis Rheum. 38:1995;384-388.
8. Hashimoto K., Whitehurst C. E., Matsubara T., Hirohata K., Lipsky P. E. Immunomodulatory effects of therapeutic gold compounds: Gold sodium thiomalate inhibits the activity of T cell protein kinase C. J. Clin. Invest. 89:1992;1839-1848.
9. Matsubara T., Ziff M. Inhibition of human endothelial cell proliferation by gold compounds. J. Clin. Invest. 79:1987;1440-1446.
10. Hirohata S., Lipsky P. E. Comparative inhibitory effects of bucillamine andD. Arthritis Rheum. 37:1993;942-950.
11. Hirohata S., Oka H. Modulation of T cell production of interferon-γ by human monocytes: Effect of engagement of CD14 on monocytes. Cell. Immunol. 151:1993;270-282.
12. Yanni G., Farahat M. N. M. R., Poston R. N., Panayi G. S. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann. Rheum. Dis. 53:1994;256-260.
13. Rovera G., Santoli D., Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA. 76:1979;2779-2783.
14. Springer T. A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
15. Lindsley H. B., Smith D. D., Davis L. S., Koch A. E., Lipsky P. E. Regulation of the expression of adhesion molecules by human synoviocytes. Semin. Arthritis Rheum. 21:1992;330-334.
16. Kavanaugh A. F., Davis L. S., Nichols L. A., Norris S. H., Rothlein R., Scharschmidt L. A., Lipsky P. E. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 37:1994;992-999.